UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

The oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1222-1231

2017

Volltextzugriff (PDF)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Infection, 2021-06, Vol.49 (3), p.559-562

2021

Volltextzugriff (PDF)

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

International journal of oncology, 2017-12, Vol.51 (6), p.1793-1800

2017

Volltextzugriff (PDF)

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1372-1381

2018

Volltextzugriff (PDF)

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Critical reviews in oncogenesis, 2017, Vol.22 (3-4), p.219

2017

Volltextzugriff (PDF)

Modelling of thrombin generation under flow in realistic left anterior descending geometries

Medical engineering & physics, 2017-12, Vol.50, p.50-58

2017

Volltextzugriff (PDF)

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

International journal of oncology, 2017-12, Vol.51 (6), p.1747-1756

2017

Volltextzugriff (PDF)

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Volltextzugriff (PDF)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

TH open : companion journal to thrombosis and haemostasis, 2022-04, Vol.6 (2), p.e89-e95

2022

Volltextzugriff (PDF)

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

BMC cancer, 2014-12, Vol.14 (1), p.991-991, Article 991

2014

Volltextzugriff (PDF)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-07, Vol.3 (3), p.e309-e315

2019

Volltextzugriff (PDF)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Clinical and applied thrombosis/hemostasis, 2018-11, Vol.24 (8), p.1347-1351

2018

Volltextzugriff (PDF)

Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764

2016

Volltextzugriff (PDF)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e340-e347

2019

Volltextzugriff (PDF)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e348-e349

2019

Volltextzugriff (PDF)

Effect of low molecular weight heparins and fondaparinux upon thrombin generation triggered by human pancreatic cancer cells BXPC3

Current vascular pharmacology, 2014-01, Vol.12 (6), p.893

2014

Volltextzugriff (PDF)

The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation

Thrombosis and haemostasis, 2004-05, Vol.91 (5), p.977

2004

Volltextzugriff (PDF)

Heparin resistance and coagulation activation rebound effect after anticoagulant withdrawal: beneficiary effect of adjuvant antiplatelet therapy

International angiology, 2016-04, Vol.35 (2), p.170

2016

Volltextzugriff (PDF)

Rapid detection of D-Dimers with mLabs® whole blood method for venous thromboembolism exclusion. Comparison with Vidas® D-Dimers assay

International angiology, 2016-12, Vol.35 (6), p.622

2016

Volltextzugriff (PDF)

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Blood, 2021-11, Vol.138 (Supplement 1), p.3213-3213

2021

Volltextzugriff (PDF)

Heterogeneity of synthetic factor Xa inhibitors

Current pharmaceutical design, 2005-01, Vol.11 (30), p.3855

2005

Volltextzugriff (PDF)

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Blood, 2022-11, Vol.140 (Supplement 1), p.11211-11213

2022

Volltextzugriff (PDF)

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Blood, 2022-11, Vol.140 (Supplement 1), p.11214-11215

2022

Volltextzugriff (PDF)

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Blood, 2020-11, Vol.136 (Supplement 1), p.26-27

2020

Volltextzugriff (PDF)

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Blood, 2020-11, Vol.136 (Supplement 1), p.4-4

2020

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Modelling of thrombin generation under flow in realistic left anterior descending geometries

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Effect of low molecular weight heparins and fondaparinux upon thrombin generation triggered by human pancreatic cancer cells BXPC3

The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation

Heparin resistance and coagulation activation rebound effect after anticoagulant withdrawal: beneficiary effect of adjuvant antiplatelet therapy

Rapid detection of D-Dimers with mLabs® whole blood method for venous thromboembolism exclusion. Comparison with Vidas® D-Dimers assay

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Heterogeneity of synthetic factor Xa inhibitors

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Aktive Filter

Suchergebnisse filtern